Product Information
SIROLIMUS 2 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $2.6413 per EA under NDC 59762100301. Its NADAC has been published 253 times since Jun 20, 2018.
FDA first approved this application on Aug 25, 2000. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
59762100301
Classification
Generic
Dosage Form
TABLET, SUGAR COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
SIROLIMUSApproval Type
Authorized Generic (NDA)
FDA Application
NDA021110FDA Approved
8/25/2000
TE Code
AB
On Market Since
10/27/2014
Pharmacological Classes
Price Statistics
The NADAC for SIROLIMUS 2 MG TABLET has been published 253 times since Jun 20, 2018, and over the history we have for it it has declined 84.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.6413 per EA |
|---|---|
| All-time high | $17.8800 (May 12, 2021) |
| All-time low | $2.6413 (Aug 19, 2026) |
| 52-week high | $5.8001 |
| 52-week low | $2.6413 |
| Median price | $5.2602 |
| Average price | $9.7985 |
| Largest weekly change | -78.7% (Oct 18, 2023) |
| Weeks tracked | 253 |
| Tracking since | Jun 20, 2018 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the SIROLIMUS market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of SIROLIMUS 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SIROLIMUS 2 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $2.6413 per EA (NDC 59762100301), effective Aug 19, 2026.
How has the price of SIROLIMUS 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for SIROLIMUS 2 MG TABLET has declined 84.5%. It has been tracked across 253 weekly CMS publications since Jun 20, 2018.
What are the highest and lowest recorded NADAC prices for SIROLIMUS 2 MG TABLET?
Since Jun 20, 2018, the NADAC for SIROLIMUS 2 MG TABLET has ranged from a low of $2.6413 (Aug 19, 2026) to a high of $17.8800 (May 12, 2021), with a median of $5.2602 per EA.
Are there cheaper alternatives to SIROLIMUS 2 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of SIROLIMUS 2 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures SIROLIMUS 2 MG TABLET?
SIROLIMUS 2 MG TABLET (NDC 59762100301) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.